throbber
Int. J. Mol. Sci. 2015, 16, 7493-7519; doi:10.3390/ijms16047493
`
`OPEN ACCESS
`
`International Journal of
`Molecular Sciences
`o modulate gut
`www.mdpi.com/journal/ijms
`
`Review
`Impacts of Gut Bacteria on Human Health and Diseases
`
`Yu-Jie Zhang 1, Sha Li 2, Ren-You Gan 3, Tong Zhou 1, Dong-Ping Xu 1 and Hua-Bin Li 1,*
`
`1 Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health,
`Sun Yat-sen University, Guangzhou 510080, China; E-Mails: zhyujie3@mail2.sysu.edu.cn (Y.-J.Z.);
`zt740359815@163.com (T.Z.); xudongping1989@163.com (D.-P.X.)
`2 School of Chinese Medicine, The University of Hong Kong, Sassoon Road, Hong Kong, China;
`E-Mail: lishasl0308@163.com
`3 School of Biological Sciences, The University of Hong Kong, Pokfulam Road, Hong Kong, China;
`E-Mail: ganry@connect.hku.hk
`
`* Author to whom correspondence should be addressed; E-Mail: hbli2000@yahoo.com or
`lihuabin@mail.sysu.edu.cn; Tel.: +86-20-8733-2391; Fax: +86-20-8733-0446.
`
`Academic Editor: Manickam Sugumaran
`
`Received: 5 February 2015 / Accepted: 26 March 2015 / Published: 2 April 2015
`
`
`Abstract: Gut bacteria are an important component of the microbiota ecosystem in the
`human gut, which is colonized by 1014 microbes, ten times more than the human cells. Gut
`bacteria play an important role in human health, such as supplying essential nutrients,
`synthesizing vitamin K, aiding in the digestion of cellulose, and promoting angiogenesis and
`enteric nerve function. However, they can also be potentially harmful due to the change of
`their composition when the gut ecosystem undergoes abnormal changes in the light of the
`use of antibiotics, illness, stress, aging, bad dietary habits, and lifestyle. Dysbiosis of the gut
`bacteria communities can cause many chronic diseases, such as inflammatory bowel
`disease, obesity, cancer, and autism. This review summarizes and discusses the roles and
`potential mechanisms of gut bacteria in human health and diseases.
`
`Keywords: gut bacteria; human health; cancer; obesity
`
`
`
`1. Introduction
`
`The human gut mucosa consists of epithelial cells, lamia propria, and the muscularis mucosae, which
`is colonized by 1014 microbes [1]. The number of these microbes is ten times more than the human cells.
`
`Genome Ex. 1051
`Page 1 of 27
`
`

`

`7494
`
`Int. J. Mol. Sci. 2015, 16
`
`Gut bacteria are important components of the microbiota ecosystem in the human gut. Commensal
`bacteria colonize in the gut shortly after birth and comprise approximate 1000 species, most of which are
`unknown species belonging to anaerobic strains [2,3]. The composition and temporal patterns of gut
`microbiota in infants varies widely and is very different from those in adults. Furthermore, the intestinal
`microbiota stabilizes to a more adult-like profile around the age of one year, usually after the
`introduction of solid foods [4]. In addition, the composition of the gut bacteria community in the
`stomach and colon is distinctive, which is mainly due to different physicochemical conditions, such as
`intestinal motility, pH value, redox condition, nutrients, host secretions (e.g., gastric acid, bile, digestive
`enzymes, and mucus), and the presence of an intact ileocaecal valve [5]. Additionally, they can be
`influenced by many factors, such as the use of antibiotics, illness, stress, aging, bad dietary habits and
`lifestyle [5,6].
`Usually, gut bacteria and the host live in a commensal manner. On the one hand, they can supply
`essential nutrients, synthesize vitamin K, aid in the digestion of cellulose, and promote angiogenesis and
`enteric nerve function [7–9]. Bacteroidetes and Firmicutes are the main bacteria in the metabolism
`of undigested food remnants. They help to digest dietary fiber and polyphenols by a complex
`metabolic energy-harvesting mechanism, which is based on cross-feeding and co-metabolism. In return,
`commensal bacteria take advantage of theprotective and nutrient-rich environment of the host [10]. Yet,
`specialized gut bacteria perform reductive reactions such as methanogenesis, acetogenesis, nitrate
`reduction, and sulfate reduction [11]. On the other hand, commensal bacteria and probiotics can
`promote barrier integrity, and prevent antigens and pathogens from entering the mucosal tissues [12].
`Besides, commensal bacteria contribute to the host defense by regulating the homeostasis of the host
`immune system [13]. However, gut bacteria can be potentially harmful when the gut ecosystem
`undergoes abnormal changes. Dysbiosis of the gut bacteria communities in patients or animal models
`may cause allergy, inflammatory bowel disease (IBD), obesity, diabetes, and even cancer [8,9]. The
`composition of gut bacteria can indicate the risk of diseases in each person [14]. Herein, this review
`summarizes and highlights the roles and potential mechanisms of gut bacteria in human health and
`diseases. Understanding of the relationship between gut bacteria and human health can be helpful for
`targeting new probiotic treatments and novel strategies in treating and managing a wide variety of
`human diseases. The literature was sought from the databases PubMed and ISI Web of Knowledge, and
`the references cited were mainly original articles from 2005–2014.
`
`2. Gut Bacteria in Health
`
`The main gut bacterial phyla, in the order of numerical importance, are Firmicutes, Bacteroidetes,
`Actinobacteria, Proteobacteria, Verrucomicrobia and Fusobacteria [15]. Firmicutes are gram-positive
`bacteria with a low G + C content, including the large class of Clostridia and the lactic acid bacteria,
`while Actinobacteria are gram-positive bacteria with a high G + C content, including Colinsella
`and Bifidobacterium spp. Lactic acid bacteria and Bifidobacteria are two important types of gut
`bacteria, which are autochthonous ones from birth or acquired from digested food. Lactobacillus and
`Leuconostoc spp. are the main lactic acid bacteria found in the human intestine. Bifidobacterium spp. is
`the predominant bacteria found among the first colonizers of newborns, and persists at a low level in
`adults [16]. Gut bacteria play an important role in human health, including contributing to the host gut
`
`
`
`Genome Ex. 1051
`Page 2 of 27
`
`

`

`Int. J. Mol. Sci. 2015, 16
`
`defense system and helping the gut to maintain normal function, while its composition can be
`influenced by the host (Figure 1).
`
`7495
`
`
`
`Stomach (acid)
`
`Small intestine (bile and
`pancreatic secretions)
`
`(space and
`Colon
`nutrients)
`
`Bacteria: 103 cells/ml
`contents;
`e.g.,
`Helicobacter pylori
`
`Bacteria: 104-106 cells/g
`contents; e.g., lactobacilli,
`Gram positive cocci
`GALT: mucosal adaptive
`immune activity
`
`Bacteria: 1012 cells/g contents;
`e.g., bifidobacteria, lactobacilli,
`bacteroides, enterobacteria,
`enterococci, sulphate reducers,
`methanogens
`Major metabolic activity
`Short chain fatty acids
`
`
`
`Figure 1. Reciprocal relationship between human gut bacteria and the host.
`
`2.1. Gut Bacteria and Gut Immune System
`
`The gut resists pathogenic bacteria through two barriers, the mechanical barrier and the immune
`barrier. The mechanical barrier consists of a single layer of polarized intestinal epithelial cells,
`the enterocytes and mucus. On the other hand, secreted immunoglobulin A (IgA), intraepithelial
`lymphocytes, macrophages, neutrophils, natural killer cells, Peyer’s plaques, and mesenteric lymph
`node compose the immune barrier. Commensal bacteria and probiotics can promote the integrity
`of gut barriers. Commensal bacteria contribute to the host gut defense system mainly by resisting the
`invasion of pathogenic bacteria and helping the development of the host immune system. Gut bacteria
`maintain resistance against the colonization of pathogenic bacteria by competing for nutrients and
`attachment sites on the mucosal surface in the colon, a phenomenon collectively known as “colonization
`resistance” [17]. The invasion of pathogenic bacteria is also prevented by commensal bacteria due to the
`reduction of the intestinal pH by the production of lactate and short-chain fatty acids (SCFAs) [9].
`Another way is by producing toxic or carcinogenic metabolites to inhibit the growth or kill
`potentially pathogenic bacteria, together with volatile fatty acids that can inhibit the colonization of
`pathogenic bacteria. For example, proteolytic fermentation in the distal colon could produce toxic,
`carcinogenic metabolites such as bacteriocins, ammonia, indoles, and phenols by gut bacteria [18].
`Lipopolysaccharides (LPSs) and peptidoglycan (PGN) components in the bacterial cell wall are two
`kinds of pathogen-associated molecular patterns, and they can individually or synergistically activate
`nuclear factor κB (NF-κB) effector and further induce the production of inflammatory cytokines such as
`tumor necrosis factor α (TNF-α), interleukin 1β (IL-1β) and antimicrobial peptides in the defense
`against foreign pathogens. Chronic stimulation of pattern-recognition receptors (PRRs) by PGN can
`
`
`
`Genome Ex. 1051
`Page 3 of 27
`
`

`

`7496
`
`Int. J. Mol. Sci. 2015, 16
`
`also minimize excessive tissue injury induced by intestinal antigen-presenting cells, which can
`produce inhibitory cytokines such as transforming growth factor β (TGF-β) and IL-10 via nuclear
`oligomerization domain-2 dependent pathways [19].
`Peyer’s patches, lamina propria lymphocytes, intra-epithelial lymphocytes and mesenteric lymph
`nodes constitute gut-associated lymphoid tissue (GALT), which is the main part of the gut immune
`system. Gut bacteria prime the dendritic cells (belonging to lamina propria lymphocytes) of the immune
`system. L. plantarum was suggested to regulate human intestinal epithelial tight-junction proteins and
`show protective effects against chemical-induced disruption of the epithelial barrier [12]. It has been
`found that antibody repertoire diversification occurred in GALT after birth and was stimulated by gut
`bacteria in sheep, cattle, pigs, and rabbits [20]. It was hypothesized this action may also occur in
`humans. Gut bacteria including Bacteroides fragilis and Bacillus are probably required for the normal
`development of GALT and mucosal immunity in all mammals. They are also required for somatic
`diversification of immunoglobulin (Ig) genes. Gut bacteria colonization induces a conspicuous response
`of the gut immune system to the production of IgA, which plays a critical role in regulation of gut
`bacterial communities in the small intestine. Another factor that may play an active role in the induction
`of local immune responses is the ILs, which may function as sensors of gut bacteria [10].
`Studies of animals bred under germ-free conditions showed that germ-free animals presented
`morphological, structural, and functional abnormalities, including “reduced vascularity, digestive
`enzyme activity, muscle wall thickness, cytokine production and serum immunoglobulin levels, smaller
`Peyer’s patches and fewer intra-epithelial lymphocytes” [21]. Another study showed that animals
`received cells from germ free mice developed an earlier onset of colitis, and CD4+CD62L− cells from
`germ free mice were not able to ameliorate colitis compared with mice reconstituted with lymphocytes
`from conventionally housed animals [22]. The study also assumed a lack of Treg cells within germ
`free mice by observing the higher percentage of CD4+GITR+ expressing lymphocytes and the production
`of IL-10 after priming by dendritic cells, which suggested the presence of Treg cells within the
`CD4+CD62L+ lymphocyte subset derived from conventional housed mice. Butyrate, produced by
`commensal microorganisms during starch fermentation, may facilitate extrathymic generation of Treg
`cells [23].
`
`2.2. Gut Bacteria Benefit the Host
`
`Not only do gut bacteria benefit the host by contributing to the host gut defense system, they also
`help the gut to maintain normal functions. Gut bacteria benefit the host in a variety of ways, such as
`regulating gut motility, producing vitamins, transforming bile acid and steroids, metabolizing xenobiotic
`substances, absorbing minerals, and activating and destroying toxins, genotoxins, and mutagens [24].
`The proximal region of colon produces a great quantity of short-chain organic acids, such as acetic,
`propionic, and butyric acids. Theses organic acids are energy sources for the colonic mucosa and
`peripheral body tissues, and they are metabolites of undigested complex carbohydrates by colonic
`bacteria fermentation. In return, theses organic acids affect bacterial growth in the colon by
`affecting colonic water absorption and decreasing fecal pH. In addition, Oxalibacterium formigenes,
`a betaproteobacterium within the order Burkholderiales, which is among the putative core bacteria,
`
`
`
`Genome Ex. 1051
`Page 4 of 27
`
`

`

`7497
`
`Int. J. Mol. Sci. 2015, 16
`
`is one of the few colonic bacteria with well-defined health benefits. They regulate the homeostasis of
`oxalic acid and prevent the formation of kidney stones [25].
`Gut bacteria are essential for the transformation of natural compounds (e.g., lignans) to perform their
`bioactivities. Lignans are present in a wide range of foods, such as flaxseed, vegetable, fruit, and
`beverages. Lignans afford protection against cardiovascular diseases, hyperlipidemia, breast cancer,
`colon cancer, prostate cancer, osteoporosis and menopausal syndrome, dependent on the bioactivation of
`these compounds to enterolactone (ENL) and enterodiol [26,27]. Gut bacteria are required for the
`production and bioavailability of these enterolignans. Secoisolariciresinol is one of the most abundant
`dietary lignans, and it can be demethylated and dehydroxylated by two gut bacteria isolated from
`human feces, named Peptostre ptococcus SECO-Mt75m3 and Eggerthella lenta SECO-Mt75m2 [28].
`Gut bacteria also play an essential role in the metabolism of isoflavones, and the metabolites are more
`biologically active than their precursors. Isoflavones are structurally similar to the mammalian estrogen,
`and soy foods are the predominant food sources of them. Isoflavones have protective activity in
`breast cancer, prostate cancer, cardiovascular disease, osteoporosis, and menopausal symptoms [29].
`In addition, De Fillippo et al. [14] reported that gut bacteria protected African children from the risk of
`infectious and noninfectious colonic diseases by coevolving with the polysaccharide-rich diet, which
`also allowed them to maximize energy intake from fibers.
`
`2.3. Dietary Influence on Gut Bacteria
`
`The colonization of gut bacteria is influenced by many factors, such as the living environment and
`diet (Figure 2). The feeding ways of infants was reported to impact the composition of gut bacteria.
`Infants fed with breast milk had higher levels of Bifidobacteria spp., while infants fed with formula had
`higher levels of Bacteroides spp., Clostridium coccoides and Lactobacillus spp. [30–32]. Besides, the
`host physiologic process, the anatomical structure and physiology of the digestive tract are major
`factors [24]. They may cause changes to the disease structure in the host. It was proved that diets could
`impact the composition of gut bacteria. A study showed that mice fed with Western-diet and
`low-fat-chow-diet displayed different structures of gut bacteria. The relative abundance was increased
`about 1.2-fold for Bacteroidetes and 18-fold for Proteobacteria, while was decreased about 1.5-fold
`for Firmicutes in mice fed with Western-diet. Members of the Desulfovibrionaceae family were
`significantly enriched in the cecal contents of healthy mice fed with Western-diet. Lactobacillus gasseri
`species were found representing 4.3% of total bacteria on average, and Ruminococcus and other
`members of Lachnospiraceae and Bacteroidales were also enriched in mice fed with low-fat-chow-diet.
`Lactobacillus gasseri species were even absent in mice receiving Western-diet [33]. There are also
`studies reporting that long-term and short-term diets influence the composition and function of the gut
`microbiota in humans. In a study of diet inventories and 16S rDNA sequencing to characterize fecal
`samples from 98 individuals, enterotypes were strongly associated with long-term diets, particularly
`protein and animal fat (Bacteroides) versus carbohydrates (Prevotella). Microbiome composition
`changed detectably within 24 h of initiating a high-fat/low-fiber or low-fat/high-fiber diet, but that
`enterotype identity remained stable during the 10-days in a controlled-feeding study of 10 subjects [34].
`Another study showed the short-term consumption of diets composed entirely of animal meat, eggs, and
`cheeses or plant rich in grains, legumes, fruits, and vegetables, altered microbial community structure
`
`
`
`Genome Ex. 1051
`Page 5 of 27
`
`

`

`Int. J. Mol. Sci. 2015, 16
`
`and overwhelmed inter-individual differences in microbial gene expression. The animal-based diet
`increased the abundance of bile-tolerant microorganisms and decreased the levels of Firmicutes
`that metabolize dietary plant polysaccharides. The bile-tolerant microorganisms included Alistipes,
`Bilophila, and Bacteroides, and Firmicutes
`included Roseburia, Eubacterium rectale, and
`Ruminococcus bromii. Both diets also altered microbial metabolic activity. The animal-based diet
`resulted in significantly lower levels of the products of carbohydrate fermentation and a higher
`concentration of the products of amino acid fermentation compared with the plant-based diet and
`baseline samples [35].
`
`7498
`
`
`
`External influences
`
`Diet; Prebiotics;
`Probiotics;
`Antibiotic usage;
`Illness; Lifestyle;
`Living environment
`
`
`Health
`
`homeostasis
`
`Density, diversity
`and activity of
`the gut bacteria
`
`Dysbiosis
`
`Diseases
`
`Internal host properties
`
`Stress;
`Age; Genetics;
`Physiologic processes; The
`anatomical
`structure
`and physiology of
`the
`digestive tract
`
`
`
`
`Figure 2. Several factors influence the density, diversity, and activity of the gut bacteria.
`
`Further study found that dietary factors such as polyphenols, fibers, and carbohydrates had the ability
`to modify the balance of gut bacteria. Phenolic acids and flavonoids are the main polyphenols of our
`dietary intake. It was shown that tea phenolics and their derivatives repressed the growth of certain
`pathogenic bacteria such as Clostridium perfringens, Clostridium difficile, and Bacteroides spp., while
`they less severely affected commensal anaerobes, such as Clostridium spp., Bifidobacterium spp., and
`Lactobacillus sp. [36]. Parkar et al. [37] found dietary polyphenols may modify the gut bacteria balance
`indirectly by their biotransformation products rather than the original plant compounds. In that study,
`fermentation of polyphenols increased proliferation of Bifidobacteria and decreased the ratio of
`Firmicutes to Bacteroidetes, compared to controls. Furthermore, among the polyphenols studied, caffeic
`acid at 100 mg/mL stimulated the greatest absolute increases of gut bacteria. Polyphenols also
`stimulated the production of short chain organic acids by the gut bacteria. Fiber was another dietary
`factor that impacted the composition of gut bacteria. A study showed that subjects on a fiber-blend
`fortified enteral formula had less negative symptoms related to bowel urgency, and decreases in total
`bacteria and Bifidobacteria were less severe compared with the fiber-free formula [38]. Polyphenols
`and fibers were thought to be beneficial dietary factors. Functional foods based on these beneficial
`dietary factors may provide opportunities to modulate the bacteria balance in the gut. In addition,
`a recent study showed the pH of drinking water could also affect the composition and diversity of
`commensal bacteria in the gut [39].
`However, some dietary factors may be harmful, such as dietary iron. Dietary iron mostly from red
`meat and fortified cereals can also change the gut bacteria composition. Other luminal iron is from
`
`
`
`Genome Ex. 1051
`Page 6 of 27
`
`

`

`7499
`
`Int. J. Mol. Sci. 2015, 16
`
`cigarette smoking. Increased iron availability may increase the proliferation and virulence of gut bacteria
`and increase the permeability of the gut barrier. A study showed that increased iron exposure contributed
`to the colonization of certain bacterial pathogens including Salmonella [40]. It may be a risk factor for
`colorectal cancer. The composition of intestinal bacteria could also be regulated by traditional Chinese
`herbs. The five hydroxyanthraquinone derivatives from Rheum palmatum had inhibitive effects on
`Bifidobacterium adolescentis growth [41]. The most effective component in R. palmatum to restrain the
`growth of B. adolescentis was rhein.
`It was proved that prebiotics could influence the composition of gut bacteria to benefit the host.
`Prebiotics are defined as a non-digestible food ingredient that beneficially affects the host by selectively
`stimulating the growth and/or activity of one or a limited number of bacteria in the colon, and thus
`improving the hosts’ health [42]. Prebiotics are carbohydrate-like compounds, such as lactulose and
`resistant starch, and have been used in the food industry to modify the composition of the microbiota
`species to benefit human health in recent years [43]. Inulin is one type of prebiotics. These prebiotics
`mostly target bifidobacteria and lactobacilli, which are two kinds of probiotics [44]. Probiotics are
`living non-pathogenic organisms used as food ingredients to benefit the hosts’ health. They may be lactic
`acid bacteria, Bifidobacteria, or yeasts, such as Saccharomyces cerevisiae [45,46]. Furthermore,
`probiotics can be used in the treatment of hepatic encephalopathy, inflammatory bowel diseases,
`infections, hypertension, cancer, and atopic dermatitis in children [46–50].
`
`3. Gut Bacteria and Diseases
`
`Usually, gut bacteria and the host live in a commensal manner. However, gut bacteria
`can be potentially harmful when the ecosystem undergoes abnormal changes. Dysbiosis of the gut
`bacteria communities in patients or animal models may cause many diseases. For example, antibiotic
`treatment and surgery cause pseudomembranous colitis due to toxin production by Clostridium difficile
`and sepsis of Escherichia coli, Enterococcus faecalis and Enterococcus faecium, and intra-abdominal
`abscesses due to Bacteroides fragilis [51]. Imbalance in gut bacteria composition was associated with
`intestinal symptoms, such as bloating, abdominal pain, and diarrhoea. Uncultured phylotypes from
`Clostridium clusters IV and XIVa had statistically significant positive correlation with bloating.
`Anaerotruncus colihominis, Ruminococcus callidus and Lachnospira pectinoschiza were higher when
`bloating was recorded. The abundance of bifidobacteria may have a negative correlation with abdominal
`pain. In addition to bifidobacteria, one phylotype within Ruminococcus lactaris, Clostridium cluster IV,
`was significantly decreased in pain associated samples. Among the positive correlations, uncultured,
`potentially pathogenic phylotypes within uncultured Clostridiales II, Anaerotruncus colihominis and
`Ruminococcus callidus, were increased over ten-fold when pain was recorded [25]. Diarrhea was
`associated with a reduced number of members from the genus Streptococcus, particularly S. alactolyticus [15].
`Besides, many other diseases are related to gut bacteria, such as inflammatory bowel diseases, obesity,
`diabetes, liver diseases, chronic heart diseases, cancers, HIV, and autism.
`
`3.1. Gut Bacteria and Inflammatory Bowel Diseases
`
`Inflammatory bowel disease (IBD) is most common in the developed countries of Europe, the U.S.,
`and Scandinavia [24]. Reciprocal interaction between commensal gut bacteria and the host may induce
`
`
`
`Genome Ex. 1051
`Page 7 of 27
`
`

`

`7500
`
`Int. J. Mol. Sci. 2015, 16
`
`allergies and IBD. Overly aggressive Th-1 mediated cytokine response to commensal bacteria may be
`the pathogen of chronic intestinal inflammation [52]. In addition, disorders in bacterial recognition by
`macrophages are strongly related to pathogenesis of IBD. Furthermore, IBD could results from an abnormal
`immune response against the commensal microbiota in a genetically susceptible host. Jostins et al. [53]
`have identified 163 risk loci associated with IBD, and found that many loci were involved in the sensing
`and elimination of bacteria. A hypothesis is that the innate immune system in IBD patients could be
`deficient, which in turn leads to an uncontrolled adaptive response.
`Ulcerative colitis (UC) is one of the two major idiopathic IBDs [54]. In UC patients, the disease is
`limited to the colon. Numbers of lactobacilli were significantly lower during the active phase of the
`disease, and denaturing gradient gel electrophoresis analysis suggested that Lactobacillus salivarus,
`Lactobacillus manihotivorans and Pediococcus acidilactici were present in remission, but not during
`active inflammation [55]. Besides, the colonic bacterial communities from diseased mice were less
`complex, indicating less diversity of bacterial composition during acute inflammation. Bacteria of the
`Clostridiales group were more prominent in samples from the inflamed colon, indicating these bacteria
`might accumulate during colitis [56]. In a study of an animal colitis model, E. coli may have served
`as a biomarker for colitis severity. The development of colitis is associated with higher E. coli loads,
`and bacterial TLR2 ligands may contribute to colitis pathology. Bacterial products exacerbate
`acute
`inflammation via TLR2- and TLR4-signaling and potentially
`trigger TLR-dependent
`accumulation of neutrophiles and T-cells. IL-10−/− mice developed Th1-dominant colitis via IL-12
`and IL-23 hyperproduction through bacteria recognition by abnormally differentiated subsets of
`intestinal macrophages [57]. A recent study observed a reduction of Roseburia hominis and
`Faecalibacterium prausnitzii in fecal samples of UC patients, and both species showed an inverse
`correlation with disease activity [58]. UC patients had different gene expression profiles and lower
`levels of biodiversity than their healthy twins, as well as unusual aerobic bacteria. They also had lower
`percentages of potentially protective bacterial species (e.g., Lachnospiraceae and Ruminococcaceae
`families) than their healthy twins. The colonic microbiota appeared to interact with the transcriptional
`profile of the mucosa. This interaction appeared to be lost in the colon of UC patients. Bacterial
`functions, such as butyrate production, might affect mucosal gene expression [59]. It has been suggested
`that prebiotic combination (a combination of chicory-derived long-chain inulin and oligofructose)
`reduced colitis in HLA-B27 transgenic rats, associating with alterations to the gut bacteria, decreased
`proinflammatory cytokines, and increased immunomodulatory molecules [52].
`Crohn’s disease (CD) is another type of IBDs. It has been thought to be an autoimmune disease,
`in which the body’s immune system attacks the gastrointestinal tract and causes inflammation [60].
`Seksik et al. [61] found that the fecal microflora in patients with both inactive and active colonic
`CD contained significantly more enterobacteria than in healthy subjects. In addition, about 30% of
`the dominant bacteria did not belong to the usual dominant phylogenetic groups. Another study
`found that five bacterial species characterised dysbiosis in CD patients, which were a decrease in
`Dialister invisus, an uncharacterised species of Clostridium cluster XIVa, Faecalibacterium prausnitzii
`and Bifidobacterium adolescentis, and an increase in Ruminococcus gnavus. There was a different
`composition of gut microbiota in unaffected relatives of patients with CD compared with healthy
`controls. This dysbiosis was not characterized by lack of butyrate producing-bacteria as observed in
`CD but suggested mucin-degradation capacity of microorganisms [62]. In addition, an increased
`
`
`Genome Ex. 1051
`Page 8 of 27
`
`

`

`7501
`
`Int. J. Mol. Sci. 2015, 16
`
`including Enterobacteriaceae, Pasteurellacaea, Veillonellaceae, and
`in bacteria
`abundance
`Fusobacteriaceae and decreased abundance in Erysipelotrichales, Bacteroidales, and Clostridiales,
`correlated strongly with disease status in a large pediatric CD cohort study. The study also indicated that
`antibiotic use amplified the microbial dysbiosis associated with CD. It suggested as well that assessing
`the rectal mucosal-associated microbiome offered unique potential for convenient and early diagnosis of
`CD at this early stage of disease [63]. Exclusive enteral nutrition treatment significantly changed gut
`bacterial composition, and the changes of gut Bacteroides species were associated with reduced
`inflammation in CD patients [64]. However, resident Bifidobacteria and Lactobacilli did not suppress
`the growth of disease-inducing Bacteroides species or clostridia to mediate protective action.
`Furthermore, several studies showed that prebiotic and probiotic use has an effect on the induction of
`remission in IBD patients [65]. In general, gut bacteria take a critical role in the development of IBD
`through the regulation of inflammation in the gut.
`
`3.2. Gut Bacteria and Obesity
`
`Normal gut bacteria play an important role in diet-induced obesity, because germ-free mice have been
`reported to be thinner and did not become adipose when subjected to high-fat diet [66]. The high-fat diet
`altered the composition of bacteria to display higher levels of luminal Firmicutes and Proteobacteria
`and lower levels of Bacteroidetes [67], indicating that obesity may be associated with decreased
`diversity and changes in composition of the gut bacteria. Gut bacteria is an important determinant of
`susceptibility to obesity and related metabolic diseases. The ratio of Firmicutes to Bacteroides has been
`found to be correlated to body weight, with the ratio being higher in obese people [68]. Gut bacteria
`could also affect obesity by promoting chronic inflammatory status [69]. In addition, Clostridium difficile
`infections may be another possibility of causing obesity [70]. Gut bacteria may affect obesity through
`regulation of the microbiota-brain-gut axis by its metabolites. Overweight individuals have more faecal
`SCFAs than lean individuals, with significantly increased levels of propionate. Butyrate and propionate
`were reported to protect against diet-induced obesity and regulate gut hormones via free fatty acid
`receptor 3(FFAR3)-independent mechanisms in mice [71]. SCFAs (propionate and butyrate) activated
`intestinal gluconeogenesis (IGN) by complementary mechanisms. Butyrate directly activated IGN gene
`expression via an increase in cAMP in enterocytes. Propionate, acting as a FFAR3 agonist in the
`periportal afferent neural system, induced IGN via the microbiota-gut-brain axis. A portal vein glucose
`sensor detected glucose produced by IGN and communicated to the brain by the peripheral nervous
`system to promote beneficial effects on food intake and glucose metabolism [72].
`Conjugated linoleic acid (CLA) has anti-obesity effect. Some rumen bacteria have the ability to form
`CLA from diets, such as food products from beef, milk fat, natural, and processed cheeses, yogurt, and
`plant oil. The amount of CLA in human adipose tissue is thought to be directly related to dietary intake.
`It was found that six strains (four Bifidobacterium breve strains, a Bifidobacterium bifidum strain and a
`Bifidobacterium pseudolongum strain) were able to produce different CLA and conjugated α-linolenic
`acid isomers from free linoleic acid and α-linolenic acid [73]. Lactobacillus rhamnosus PL60 is a human
`originated bacterium that produces t10, c12-CLA. A study showed that after eight weeks of feeding,
`L. rhamnosus PL60 reduced the body weight of diet-induced obese mice without reducing energy intake,
`and caused a significant, specific reduction of white adipose tissue, including epididymal and perirenal [74].
`
`
`
`Genome Ex. 1051
`Page 9 of 27
`
`

`

`7502
`
`Int. J. Mol. Sci. 2015, 16
`
`There was no observation of liver steatosis, a well known side effect of CLA by L. rhamnosus PL60
`treatment. Furthermore, oral Lactobacillus reuteri therapy alone prevented the pathology of abdominal
`obesity and age-associated weight gain in mice regardless of their baseline diet, and changed the
`pro-inflammatory immune cell profile, which was particularly dependent on CD4+ T cells and the
`presence of anti-inflammatory IL-10 [75]. In addition, an epidemiological study showed that eating
`yogurt surprisingly preven

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket